Biosynex SA announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was EUR 168.638 million compared to EUR 36.128 million a year ago. Operating income was EUR 45.734 million compared to EUR 1.597 million a year ago. Net income was EUR 31.369 million compared to EUR 1.098 million a year ago. Basic earnings per share from continuing operations was EUR 3.52 compared to EUR 0.12 a year ago. Diluted earnings per share from continuing operations was EUR 3.05 compared to EUR 0.12 a year ago.